First New Hyperbaric Indication in Medicare in 18 years in 2002: Diabetic Foot Wounds
Hundreds of Millions of Medicare Dollars Saved: An estimated $348 million is being saved
by preventing just 11% of the 158,000 amputations every year, using HBOT.
(IHMA petitioned for the Medicare National Coverage Determination, granted in 2002)
Have Ability to have this expanded to Wagner I wounds to focus on amputation prevention
to save $3 billion per year in Medicare.
Working with Congress (Registered Lobbying Team in Washington, D.C.)
TBI Treatment Act (HR 396) passed four times unanimously in the House of Representatives (died in the Senate twice)
Veterans Administration Objected to two key provisions
1) Requirement for a treatment to be effective before it was paid for.
2) Objection that a veteran would be able to be treated with effective treatment for their medical condition
without the VA being able to block the veteran from receiving that treatment.
Numerous Testimonies before Congress
2002 Labor HHS Testimony
2004 Autism Hearing
2008 Senate Suicide Prevention Hearing (Testimony for the Record)
2008 House Veterans Committee Hearing on Effective Treatments
Working with State Legislatures & Local Governments
Passage of the Oklahoma Veterans Traumatic Brain Injury Treatment and Recovery Act (SB1604) in 2014 (now law). Implementation to be modeled after HB1942 from the previous year.
Unanimous Passage of HB1942 in 2013 by OK House and Senate,
only to be killed by a parliamentary maneuver that delayed the bill for a year.
Partnered with the National Foundation for Women Legislators.
Presentations to California, Nevada, North Dakota, Oklahoma and Texas state and local governments.
Presentations to the National Football League Players Associations and Treatment of Numerous NFL players in the NBIRR-0.
Study sponsored by the IHMF
Repeated attempts to work with DoD (Department of Defense) Medicine and VA medicine to help Veterans with TBI or PTSD, including the December 5 & 6 DoD HBOT for TBI Consensus Conference
which provided them with the complete correct protocols and study design.
Note that to date not a single DoD or VA sponsored study has used the correct HBOT 1.5 protocol, nor have they
used a correct placebo treatment. All have been dosing studies and have avoided using the extensive diagnostics
that the IHMF-sponsored and Israeli studies have used.
Endorsement of the Treatment by numerous members of the Military Command structure.
(Gen. Conway, Gen Amos, Gen Chandler, Adm Mullen and others.)
Endorsement of the Treatment by each of the major National Veterans Service Organizations.
(American Legion, Veterans of Foreign Wars, Retired Officers Association, Navy League.)